The international CAR T-cell therapy market is experiencing remarkable growth, driven by growing demand for innovative cancer treatment options. This exponential expansion is fueled by contributing forces such as the acceptance of CAR T-cell therapies for multiple treatments, advancements in engineering technologies, and growing research and develo